MAC Clinical Research

MAC Clinical Research is committed to the recruitment and conduct of clinical trials for many of the world's leading pharmaceutical companies, biotechs and CRO’s. We have a broad range of clinical research capabilities to accommodate the most complex early phase trials in our MHRA Accredited Phase 1 Unit through to Phase IV across our network of late phase Dedicated Research Sites. Originally specialising in memory conditions and neurology, we have expanded our skill base to provide expertise across a diverse range of therapeutic areas, while maintaining a clear focus in neuropsychiatric disorders, neurodegenerative diseases, inflammation and pain. Attracting experienced staff from a broad range of speciality backgrounds, since inception MAC has completed over 200 studies across Phase I-IV helping us to become the UK's leading therapeutically specialised clinical trial company.